Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The study record now names Adrienne G. Waks instead of Otto Metzger, MD, and shows a new 18th version submitted on September 10, 2026, with updates to study status, sponsor/collaborators, contacts/locations, and adverse events. The latest update was posted October 2, 2026.
    Difference
    0.7%
    Check dated 2026-10-04T16:55:15.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-20T19:34:03.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-30T18:58:50.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new record revision v3.6.5 has been added to the study history. The previous revision v3.6.4 has been removed.
    Difference
    0.1%
    Check dated 2026-08-09T09:20:52.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    New revision entry v3.6.4 was added to the record history, updating the version list from the previous v3.6.3. This reflects an administrative version bump in the page's revision log with no change to study content.
    Difference
    0.1%
    Check dated 2026-07-25T18:10:08.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.3, was added to the study record history, and the previous revision, Revision: v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-04T13:19:44.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.